A Cheap, Wide-Moat Health Insurer
We're raising our fair value estimate for UnitedHealth and think investors should consider this wide-moat firm.
We're raising our fair value estimate for UnitedHealth and think investors should consider this wide-moat firm.
Jake Strole: We’ve taken a fresh look at the managed care industry and have come away a bit more constructive in our outlook, particularly in regard to UnitedHealth. We think the firm has been able to dig a wide economic moat underpinned by scale-based advantages that ensure the company touches nearly every aspect of the healthcare system.
United is the largest private insurer in the country and is expected to generate over $240 billion in net revenue during 2019. With the largest private insurance book, a leading presence in Medicare Advantage, and supporting services through its pharmacy benefits, analytics, and provider platforms, United's breadth of scope makes it the standout in the industry. The firm's wide moat is supported by cost advantages and network effects that ultimately allow for a lower claims expense per member than United's comparably smaller peers. The combination of fixed cost leverage and a better negotiating position allows the company to post best-in-class returns year in and year out.
Management has built these advantages through uniquely thoughtful capital deployment, typically adding capabilities to the business years before peers follow suit. This long-term thinking drives our high opinion of current leadership and helps us have added confidence in our long-run expectations that call for excess returns to persist well into the next decade.
Concurrent with our moat upgrade, we’ve raised our fair value estimate to $300 per share. We believe the market is likely underestimating the durability of United’s competitive advantages, putting undue emphasis on policy uncertainty over the coming years. We think shares are attractive at current market prices and encourage investors to consider an investment in this wide-moat enterprise.
Jake Strole does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.